SBIO Stock Overview
ALPS ETF Trust - ALPS Medical Breakthroughs ETF is an exchange traded fund launched and managed by ALPS Advisors, Inc.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
ALPS ETF Trust - ALPS Medical Breakthroughs ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$32.24 |
52 Week High | US$38.80 |
52 Week Low | US$23.21 |
Beta | 0 |
1 Month Change | -7.69% |
3 Month Change | -0.75% |
1 Year Change | 8.16% |
3 Year Change | -36.02% |
5 Year Change | -5.63% |
Change since IPO | 28.32% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
SBIO | US Capital Markets | US Market | |
---|---|---|---|
7D | -1.0% | -0.7% | -3.2% |
1Y | 8.2% | 23.2% | 19.3% |
Return vs Industry: SBIO underperformed the US Capital Markets industry which returned 23.2% over the past year.
Return vs Market: SBIO underperformed the US Market which returned 19.3% over the past year.
Price Volatility
SBIO volatility | |
---|---|
SBIO Average Weekly Movement | 4.3% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SBIO has not had significant price volatility in the past 3 months.
Volatility Over Time: SBIO's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | n/a | www.alpsfunds.com/exchange-traded-funds/sbio |
ALPS ETF Trust - ALPS Medical Breakthroughs ETF is an exchange traded fund launched and managed by ALPS Advisors, Inc. The fund invests in the public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, biotechnology sectors. It invests in growth and value stocks of companies across diversified market capitalization.
ALPS ETF Trust - ALPS Medical Breakthroughs ETF Fundamentals Summary
SBIO fundamental statistics | |
---|---|
Market cap | US$102.10m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SBIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SBIO income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did SBIO perform over the long term?
See historical performance and comparison